Seagen nears six-month high as Wall Street cheers Q4 results

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

Seagen (NASDAQ:SGEN) added ~15% on Thursday to reach the highest level since August after Wall Street issued positive remarks on the cancer drugmaker’s Q4 2022 results that beat expectations.

Raymond James analyst Dane Leone upgraded Seagen (SGEN